FDA Approved: ABILIFY — Supplemental Application (Otsuka America Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved a supplemental NDA for ABILIFY (aripiprazole) submitted by Otsuka America Pharmaceutical, Inc., to modify the product labeling through a supplement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

SUPPL AP for ABILIFY (ARIPIPRAZOLE)